Loading...
XNAS
PWRL
Market cap465mUSD
Sep 28, Last price  
10.76USD
1D
-2.27%
1Q
-26.70%
Name

Hill-Rom Holdings Inc

Chart & performance

D1W1MN
XNAS:PWRL chart
P/E
—
P/S
—
EPS
5.75
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
6.38%
Revenues
3.02b
+4.78%
1,757,000,0002,042,000,0001,829,000,0001,938,000,0001,962,900,0002,023,700,0001,507,700,0001,386,900,0001,469,600,0001,591,700,0001,634,300,0001,716,200,0001,686,100,0001,988,200,0002,655,200,0002,743,700,0002,848,000,0002,907,300,0002,881,000,0003,018,700,000
Net income
249m
+11.43%
-10,000,000138,000,000110,000,000-94,000,000221,200,000190,600,000115,800,000-405,000,000125,300,000133,300,000120,800,000105,000,00060,600,00047,700,000124,100,000133,600,000252,400,000152,200,000223,000,000248,500,000
CFO
476m
-1.16%
328,000,000376,000,000348,000,000240,000,00029,100,000285,900,000270,500,000225,700,000139,800,000222,500,000261,700,000263,200,000210,300,000213,800,000281,200,000311,100,000395,200,000401,400,000481,700,000476,100,000
Dividend
Dec 21, 20260.0812 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Hill-Rom Holdings, Inc. functions as a global enterprise specializing in medical technology, structured into three primary operational areas: Patient Support Systems, Front Line Care, and Surgical Solutions. The Patient Support Systems division provides a variety of essential equipment, including medical-surgical, intensive care unit, and bariatric patient beds, alongside patient lifts and related devices, non-invasive therapeutic surfaces, and cutting-edge information technology and software. This segment also offers service contracts for its capital equipment. Under its Front Line Care offerings, the company furnishes comprehensive patient monitoring and diagnostic instruments. These encompass general patient examination and diagnostic tools, continuous patient monitoring systems, diagnostic cardiology products, and vision screening devices. Additionally, it supplies a suite of respiratory health products, such as the Vest System, VitalCough System, MetaNeb System, Monarch, and Life2000, all designed to facilitate the mobilization of retained blockages in patients. The Surgical Solutions segment delivers critical operating room infrastructure, including surgical tables, specialized lighting, and ceiling-mounted pendants. It also manufactures precision positioning devices for various procedures like shoulder, hip, spinal, and lithotomy surgeries, along with universal positioning accessories compatible with diverse operating room tables. Hill-Rom's products and services reach a broad spectrum of healthcare providers. They are distributed and leased directly to acute and extended care facilities through its dedicated sales force and various distributors. The company also sells and rents directly to individual patients for home use and supplies primary care facilities via distribution partners. Its comprehensive clinical offerings cater to acute care, primary care, and even clinical research organizations. Established in 1969, Hill-Rom Holdings, Inc. maintains its headquarters in Chicago, Illinois.

Related entities

Parent

Key people

Jose Almeida
Chief Executive Officer
Karen Leets
Chief Financial Officer
Ellen Bradford
Company Secretary
IPO date
May 22, 1981
Employees
10,000
Domiciled in
US
Incorporated in
US
Legal address
C/O C T CORPORATION SYSTEM
334 North Senate Avenue
Indianapolis, IN 46204
US
Headquarters
One Baxter Parkway
Deerfield, IL 60015
US
Previous name
HILLENBRAND INDUSTRIES INC

Valuation

Title
in thousands, except ratios and share amounts
FYFYFYFYFY
2021‑092020‑092019‑092018‑092017‑09
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT